Sumatriptan (Migratan (100 mg)) is a selective serotonin receptor agonist, prescribed for the acute treatment of migraine attacks with or without aura in adults (severe, throbbing headaches that ...
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories (NYSE:RDY) today announced that it has launched the authorized generic version of GlaxoSmithKline's Imitrex® (sumatriptan succinate) tablets ...
Triptans are effective medicines used to treat migraine headaches. They significantly reduce pain within two hours for most people. Complete relief is less common, but the likelihood may be greater if ...
Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine --Migraine Sufferers ...
1 Pediatric Headache Fellow, Department of Pediatric Neurology, Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, 778 Long Ridge Rd, Stamford, CT 06902, USA. 2 ...
Ranbaxy announced that it has settled all matters relating to possible patent litigation with GlaxoSmithKline regarding Sumatriptan Succinate tablets, used for treating migraine. NEW DELHI: Ranbaxy ...
BRIDGEWATER, N.J. Dr. Reddy’s announced Monday that it has launched an authorized generic version of GlaxoSmithKline’s Imitrex (sumatriptan succinate) tablets in 25mg, 50mg, and 100mg strengths. The ...
--Migraine Sufferers Achieved Greater Rates of Pain Relief and Pain Freedom Within 30 Minutes with AVP-825 Treatment Compared with Oral Sumatriptan Treatment-- ALISO VIEJO, Calif., June 10, 2014 ...
Dr. Reddy’s Laboratories (NYSE:RDY) today announced that it has launched the authorized generic version of GlaxoSmithKline’s Imitrex® (sumatriptan succinate) tablets 25mg, 50mg, and 100mg in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results